ANGPT1 methylation and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage patients
- PMID: 35359917
- PMCID: PMC8967216
- DOI: 10.1186/s43682-021-00001-7
ANGPT1 methylation and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage patients
Abstract
Background: Delayed cerebral ischemia (DCI) is a common secondary complication and an important cause of disability and mortality among patients who survive aneurysmal subarachnoid hemorrhage (aSAH). Knowledge on DCI pathogenesis, risk factors, and biomarkers are essential for early detection and improved prognosis. To investigate the role of DNA methylation in DCI risk, we conducted an epigenome-wide association study (EWAS) in 68 patients followed up to 1 year after the initial aneurysm rupture. Blood samples were collected within 48 h post hemorrhage and used for DNA methylation profiling at ~ 450k CpG sites. A separate cohort of 175 patients was sequenced for the top CpG sites from the discovery analysis for a replication of the EWAS findings.
Results: EWAS did not identify any epigenome-wide significant CpGs. The top signal, cg18031596, was annotated to ANGPT1, a gene with critical functions in angiogenesis after vascular injury. Post hoc power calculations indicated a well-powered discovery analysis for cg18031596. Analysis of the replication cohort showed that four out of the five CpG sites sequenced at the ANGPT1 locus passed a Bonferroni-adjusted significance threshold. In a pooled analysis of the entire sample, three out of five yielded a significant p-value, and the top association signal (p-value = 0.004) was seen for a CpG that was not originally measured in the discovery EWAS. However, four ANGPT1 CpG sites had an opposite effect direction in the replication analysis compared to the discovery EWAS, marking a failure of replication. We carefully examined this observed flip in directions and propose several possible explanations in addition to that it was a random chance that ANGPT1 ranked at the top in the discovery EWAS.
Conclusions: We failed to demonstrate a significant and consistent effect of ANGPT1 methylation in DCI risk in two cohorts. Though the replication attempt to weaken the overall support of this gene, given its relevant function and top rank of significance in the EWAS, our results call for future studies of larger aSAH cohorts to determine its relevance for the occurrence of DCI.
Keywords: ANGPT1; Aneurysmal subarachnoid hemorrhage; Delayed cerebral ischemia; Epigenome-wide association study; Methylation.
Conflict of interest statement
Competing interests The authors declare no conflict of interest.
Figures




Similar articles
-
Genome-wide blood DNA methylation analysis in patients with delayed cerebral ischemia after subarachnoid hemorrhage.Sci Rep. 2020 Jul 10;10(1):11419. doi: 10.1038/s41598-020-68325-3. Sci Rep. 2020. PMID: 32651463 Free PMC article.
-
Case-control meta-analysis of blood DNA methylation and autism spectrum disorder.Mol Autism. 2018 Jun 28;9:40. doi: 10.1186/s13229-018-0224-6. eCollection 2018. Mol Autism. 2018. PMID: 29988321 Free PMC article.
-
Genetic Variability and Trajectories of DNA Methylation May Support a Role for HAMP in Patient Outcomes After Aneurysmal Subarachnoid Hemorrhage.Neurocrit Care. 2020 Apr;32(2):550-563. doi: 10.1007/s12028-019-00787-4. Neurocrit Care. 2020. PMID: 31346934 Free PMC article.
-
Efficacy of Statins in Cerebral Vasospasm, Mortality, and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.World Neurosurg. 2019 Nov;131:e65-e73. doi: 10.1016/j.wneu.2019.07.016. Epub 2019 Jul 8. World Neurosurg. 2019. PMID: 31295598
-
The Role of the Glycocalyx in the Pathophysiology of Subarachnoid Hemorrhage-Induced Delayed Cerebral Ischemia.Front Cell Dev Biol. 2021 Sep 3;9:731641. doi: 10.3389/fcell.2021.731641. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34540844 Free PMC article. Review.
Cited by
-
The Role of Epigenetics in Brain Aneurysm and Subarachnoid Hemorrhage: A Comprehensive Review.Int J Mol Sci. 2024 Mar 19;25(6):3433. doi: 10.3390/ijms25063433. Int J Mol Sci. 2024. PMID: 38542406 Free PMC article. Review.
-
Differential DNA methylation associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a systematic review.Neurosurg Rev. 2024 Apr 10;47(1):144. doi: 10.1007/s10143-024-02381-5. Neurosurg Rev. 2024. PMID: 38594575 Free PMC article.
References
-
- Ducruet AF, Gigante PR, Hickman ZL, Zacharia BE, Arias EJ, Grobelny BT, et al. Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after aneurysmal subarachnoid hemorrhage. Journal of Cerebral Blood Flow & Metabolism Nature Publishing Group. 2010;30(4): 676–88. 10.1038/jcbfm.2009.278. - DOI - PMC - PubMed
-
- Heinsberg LW, Arockiaraj AI, Crago EA, Ren D, Shaffer JR, Sherwood PR, et al. Genetic variability and trajectories of DNA methylation may support a role for HAMP in patient outcomes after aneurysmal subarachnoid hemorrhage. Neurocrit Care Springer US. 2020;32(2):550–63. 10.1007/s12028-019-00787-4. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous